In the absence of p53, O-GlcNAcylation of other proteins as a result of increased HBP and OGT activity may increase their ability to promote tumor growth, potentially explaining how O-GlcNAcylation can also be associated with more aggressive clinical behavior of CLL cells. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.